Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A Refined View on the Association Between Y-chromosome Microdeletions and Sperm Concentration

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Perspectives on a Global Change in Testicular Cancer Incidence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Patterns of Knowledge Acquisition Among Men Undergoing Radical Prostatectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Robotic versus laparoscopic urological surgery: incidence of reoperation and complications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Microwawe ablation of renal cell carcinoma: initial safety and evaluation of loss of function in the treated kidney

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  • Lars Lund
  • Harry Nisen
  • Petrus Järvinen
  • Magnus Fovaeus
  • Eirikur Gudmundsson
  • Bjarne Kromann-Andersen
  • Börje Ljungberg
  • Frode Nilsen
  • Pernilla Sundqvist
  • Peter E Clark
  • Christian Beisland
Vis graf over relationer

Purpose: To examine the variation in venous thromboembolism prophylactic treatment (VTEP) among renal cancer patients undergoing surgery.

Materials and methods: An Internet-based questionnaire on renal tumor management before and after surgery was mailed to all Nordic departments of urology. The questions focused on the use of VTEP and were subdivided into different surgical modalities.

Results: Questionnaires were mailed to 91 institutions (response rate 53%). None of the centers used VTEP before surgery, unless the patient had a vena caval tumor thrombus. Overall, the VTEP utilized during hospitalization for patients undergoing renal surgery included early mobilization (45%), compression stockings (52%) and low-molecular-weight heparin (89%). In patients undergoing open radical Nx, 80% of institutions used VTEP during their hospitalization (23% compression stockings and 94% low-molecular-weight heparin). After leaving the hospital, the proportion and type of VTEP received varied considerably across institutions. The most common interval, used in 60% of the institutions, was for a period of 4 weeks. The restriction to the Nordic countries was a limitation and, therefore, may not reflect the practice patterns elsewhere. It is a survey study and, therefore, cannot measure the behaviors of those institutions that did not participate.

Conclusion: We found variation in the type and duration of VTEP use for each type of local intervention for renal cancer. These widely disparate variations in care strongly argue for the establishment of national and international guidelines regarding VTEP in renal surgery.

OriginalsprogEngelsk
TidsskriftEuropean Urology
Vol/bind10
Sider (fra-til)181-187
Antal sider7
ISSN2253-2447
DOI
StatusUdgivet - 2018

ID: 56217495